A year after a meningitis outbreak from contaminated pain injections from a Massachusetts company killed at least 64 people and sickened hundreds, Congress is ready to increase federal oversight over compounding pharmacies that custom-mix medications.
But before the bill gets to President Barack Obama for his signature, it first has to clear a hurdle put in its path by Louisiana Sen. David Vitter. A test vote is scheduled for Tuesday evening.
SPRINGFIELD, Mass. (AP) — An attorney says a Massachusetts pharmacy blamed for a nationwide meningitis outbreak paid out more than $70 million to its owners and their other companies in the last six years.
Creditors' attorney David Molton made the disclosure Thursday at a U.S. Bankruptcy Court hearing. At the hearing, Judge Henry Boroff gave a committee of creditors the right to seek a freeze on the New England Compounding Center's assets.
Molton had argued the company had a history of removing its assets.
A Massachusetts company has denied negligence in connection with a steroid linked to a fungal meningitis outbreak that has claimed 34 lives nationwide.
New England Compounding Pharmacy filed documents Monday in response to a federal lawsuit in Minnesota. Barbe Puro claims she suffered emotional distress after receiving a steroid that may have been contaminated.
A company with the same founders as a specialty pharmacy tied to a deadly meningitis outbreak has agreed to extend its voluntary closure until Nov. 19.
Ameridose shut down for inspection Oct. 10 amid a growing outbreak linked to a tainted steroid made by the New England Compounding Center. Ameridose and NECC have the same founders, Barry Cadden and Greg Conigliaro, though Cadden has since resigned from Ameridose.